accelerating biopharma discovery
Accelerating Biopharma Discovery with Machine Learning Point B
A biopharmaceutical company wanted to launch an ambitious machine learning (ML) experiment as part of its corporate strategic initiative. The goal: to better understand ML and define an ML strategy to help bring new therapeutics to patients in less time. The entire project, which included multiple work streams, had a six-month timeframe from scoping and resourcing to execution. Due to the fast pace and high visibility, leadership knew that a senior project leader was essential to success. Our client engaged Point B to lead the initiative and help lay the foundation for an ML strategy that would accelerate discovery and innovation.